Alpha Growth Regulatory News (ALGW)

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Alpha Growth plc

("Alpha" or the "Company")

Acquisition of Havelet Assignment Company completed

Alpha Growth plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services specialist in the growing life insurance and longevity asset class, is pleased to announce that it has now completed its previously announced (17 November 2022) acquisition of Havelet Assignment Company Limited ("Havelet"), a Barbados based financial services company specialising in settlement assignments (the "Acquisition").

Key points on the Acquisition:

· The Acquisition adds circa $9 million AUM to Alpha

· Havelet generates revenue on a fee applied to AUM and is cash flow positive and profitable

· Alpha intends to increase marketing of Havelet services to the legal community with a view to materially increasing AUM

· The Acquisition provides Alpha Growth with additional cross-sell opportunities across its portfolio of companies, thereby further increasing AUM

Havelet, established in 2012, provides solutions to claimants and attorneys who are awarded settlements through litigation to defer receipt of their settlement on a pre-tax basis. As the settlement obligation is invested on a pre-tax basis and grows on a tax-deferred basis, there is a much larger capital base than if the settlement were received directly by the claimant, taxed, and then invested. The net result is the potential for a higher after-tax sum to be received by the claimant. Havelet is not subject to withholding tax on dividends pursuant to Barbados-US taxation arrangements.

Havelet's clients can customise deferral and payment terms; receive lump sum distributions; and select beneficiaries through annuities purchased and managed by Havelet, typically ranging from 10 to 20 years depending upon the age of the claimant and the settlement type. These annuities will be capable of being issued by the Company's wholly-owned subsidiary Providence Life Assurance Company ("Providence"), thereby increasing the cross-selling opportunities across the Alpha group. The annuities aim to provide a long-term independent stream of revenue for both Havelet and Providence.

Gobind Sahney, Executive Chairman of Alpha, commented: "I am very pleased to announce the successful completion of the Havelet acquisition, and I wish to thank all of the parties involved in the process. This was a small but strategically important acquisition for Alpha and one which provides significant opportunities to increase AUM both within the Havelet business and also Providence, our Bermuda-based life insurance business.

"As we enter into the last few weeks of the year, I think it's important to reflect on the significant progress that Alpha has made over the past couple of years. We started January 2020 with $10 million AUM and one primary offering, we finish 2022 with circa $700 million of AUM and multiple new service offerings in both our life insurance and fund business segments. A great foundation for continued growth."

** ENDS **

For more information, please visit www.algwplc.com or contact the following:

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

Longevity Assets and Non-correlation

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

Forward Looking Statements Disclaimer

Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward- looking statements, which speak only as of the date of this document. Readers should not treat the contents of this document as advice relating to legal, taxation or investment matters, and are to make their own assessments concerning these and other consequences, including the merits of information and the risks. Readers of this announcement are advised to conduct their own due diligence and agree to be bound by the limitations of this disclaimer.

Important Notice

The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change.